William Schuyler Jones, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member of the Duke Clinical Research Institute
Campus mail 2400 Pratt Street, 7037, Durham, NC 27705
Phone (919) 668-8917
Email address schuyler.jones@duke.edu

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.

I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2004 - 2005
  • Medical Resident, Medicine, Duke University, 2001 - 2004
  • M.D., University of Arkansas, Little Rock, 2001

Publications

Nanna, Michael G., and W Schuyler Jones. “Rise of the Machines: Where Virtual Processing Meets Percutaneous Coronary Intervention.” Can J Cardiol 37, no. 10 (October 2021): 1504–6. https://doi.org/10.1016/j.cjca.2021.07.010.

PMID
34371117
Full Text

Narcisse, Dennis I., Cassie B. Ford, E Hope Weissler, Steven J. Lippmann, Michelle M. Smerek, Melissa A. Greiner, N Chantelle Hardy, et al. “The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease.” Am Heart J 239 (September 2021): 135–46. https://doi.org/10.1016/j.ahj.2021.05.014.

PMID
34052213
Full Text

Bertges, Daniel J., Jens Eldrup-Jorgensen, Joseph Drozda, W Schuyler Jones, Art Sedrakyan, Mitchell W. Krucoff, Jack L. Cronenwett, and Jack L. Registry Assessment of Peripheral Interventional Devices and Superficial Femoral Artery-Popliteal Evidence Development Study Group. “Toward a better system for the sustainable development of objective performance goals for peripheral vascular interventions.” J Vasc Surg 74, no. 3 (September 2021): 1013–14. https://doi.org/10.1016/j.jvs.2021.06.025.

PMID
34425943
Full Text

Jones, W Schuyler, Lisa M. Wruck, and Adrian F. Hernandez. “Aspirin Dosing in Cardiovascular Disease. Reply.” N Engl J Med 385, no. 8 (August 19, 2021): 765. https://doi.org/10.1056/NEJMc2110476.

PMID
34407354
Full Text

Schwartz, Gregory G., Michael Szarek, Vera A. Bittner, Rafael Diaz, Shaun G. Goodman, J Wouter Jukema, Ulf Landmesser, et al. “Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.” J Am Coll Cardiol 78, no. 5 (August 3, 2021): 421–33. https://doi.org/10.1016/j.jacc.2021.04.102.

PMID
34325831
Full Text

Kochar, Ajar, Mary B. Summers, Catherine P. Benziger, Guillaume Marquis-Gravel, Darren A. DeWalt, Carl J. Pepine, Kamal Gupta, et al. “Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.” Clin Trials 18, no. 4 (August 2021): 449–56. https://doi.org/10.1177/1740774520988838.

PMID
33541120
Full Text

Writing Committee Members, Y Joseph, Catherine M. Otto, Rick A. Nishimura, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Federico Gentile, et al. “2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” J Thorac Cardiovasc Surg 162, no. 2 (August 2021): e183–353. https://doi.org/10.1016/j.jtcvs.2021.04.002.

PMID
33972115
Full Text

Weissler, E Hope, Oyomoare L. Osazuwa-Peters, Melissa A. Greiner, G Chad Hughes, Chandler A. Long, Sreekanth Vemulapalli, Manesh R. Patel, and W Schuyler Jones. “National trends in repair for type B aortic dissection.” Clin Cardiol 44, no. 8 (August 2021): 1058–68. https://doi.org/10.1002/clc.23672.

PMID
34173677
Full Text

Writing Committee Members, Y Joseph, Steve R. Ommen, Seema Mital, Michael A. Burke, Sharlene M. Day, Anita Deswal, Perry Elliott, et al. “2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” J Thorac Cardiovasc Surg 162, no. 1 (July 2021): e23–106. https://doi.org/10.1016/j.jtcvs.2021.04.001.

PMID
33926766
Full Text

Hiatt, William R., Connie N. Hess, Marc P. Bonaca, Sarah Kavanagh, Manesh R. Patel, Iris Baumgartner, Jeffrey S. Berger, et al. “Ankle-Brachial Index for Risk Stratification in Patients With Symptomatic Peripheral Artery Disease With and Without Prior Lower Extremity Revascularization: Observations From the EUCLID Trial.” Circ Cardiovasc Interv 14, no. 7 (July 2021): e009871. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009871.

PMID
34253048
Full Text

Pages